Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.
暂无分享,去创建一个
Paul E Swanson | H. Linden | S. N. Agoff | P. Swanson | S. Hawes | Stephen E Hawes | T. Lawton | Hannah Linden | S Nicholas Agoff | Thomas J Lawton | S. Agoff
[1] M. Aragno,et al. Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide , 2005, Journal of Cancer Research and Clinical Oncology.
[2] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[3] M. Bryś,et al. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies , 2002, Journal of Cancer Research and Clinical Oncology.
[4] B. Xie,et al. The role of androgens in mammary carcinogenesis. , 2001, Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia.
[5] R A Irvine,et al. Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. , 2000, Cancer research.
[6] S. Tsao,et al. Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens. , 1999, Carcinogenesis.
[7] S. Cummings,et al. Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer , 1999, Annals of Internal Medicine.
[8] J. Manson,et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.
[9] Vessey Mp. Effect of endogenous and exogenous hormones on breast cancer: epidemiology. , 1997 .
[10] T. H. van der Kwast,et al. The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. , 1996, European journal of cancer.
[11] S. Hilsenbeck,et al. Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] D. Barnes,et al. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? , 1993, Human pathology.
[13] J. Isola. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors , 1993, The Journal of pathology.
[14] J. Varhaug,et al. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[15] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[16] R. Bryan,et al. Androgen receptors in breast cancer , 1984, Cancer.
[17] F. Berrino,et al. Increased androgenic activity and breast cancer risk in premenopausal women. , 1984, Cancer research.
[18] J. Wittliff. Steroid‐hormone receptors in breast cancer , 1984, Cancer.
[19] W. McGuire,et al. The value of estrogen and progesterone receptors in the treatment of breast cancer , 1980, Cancer.
[20] E. J. Gregory,et al. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. , 1977, Cancer research.